BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2018 6:43:44 AM | Browse: 1263 | Download: 1778
Publication Name World Journal of Gastroenterology
Manuscript ID 39047
Country South Korea
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
Manuscript Source Invited Manuscript
All Author List Gyu Sang Yoo, Jeong Il Yu and Hee Chul Park
ORCID
Author(s) ORCID Number
Gyu Sang Yoo http://orcid.org/0000-0002-5542-5263
Jeong Il Yu http://orcid.org/0000-0002-2009-7263
Hee Chul Park http://orcid.org/0000-0003-0385-9681
Funding Agency and Grant Number
Funding Agency Grant Number
the Ministry of Oceans and Fisheries, Korea 20150220
Corresponding Author Hee Chul Park, MD, PhD, Professor, Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06355, South Korea. hee.ro.park@samsung.com
Key Words Radiation therapy; Hepatocellular carcinoma; Proton beam therapy; X-ray therapy
Core Tip Radiation therapy (RT) is being increasingly utilized for the treatment of hepatocellular carcinoma (HCC). As RT technology develops, proton beam therapy (PBT) has emerged as a method that affords dosimetric advantages compared with X-ray therapy due to its phy­sical properties, including lack of an exit dose along the beam path. Clinical experience with PBT for HCC is ac­cumulating rapidly, and the effectiveness and safety of PBT has been validated. In this review, we discuss the physical properties, current clinical data, technical issues, and future perspectives on PBT for the treatment of HCC.
Publish Date 2018-07-27 06:43
Citation Yoo GS, Yu JI, Park HC. Proton therapy for hepatocellular carcinoma: Current knowledge and future perspectives. World J Gastroenterol 2018; 24(28): 3090-3100
URL http://www.wjgnet.com/1007-9327/full/v24/i28/3090.htm
DOI http://dx.doi.org/10.3748/wjg.v24.i28.3090
Full Article (PDF) WJG-24-3090.pdf